Judge, 2016 Rte 128 (Boston Univ.)

Kevin Connors is an accomplished entrepreneur and venture investor. He has co-founded seven healthcare technology companies, and has had interim CEO roles in nine. These companies have focused on developing proprietary technology to address large un-met medical needs, such as emphysema, low back pain, uterine fibroids, and bladder dysfunction.

Prior to founding Spray Venture Partners in 1996, Kevin was the founding CEO of Vesica Medical, a company focused on the surgical treatment of female urinary incontinence. Under this leadership, Vesica realized product sales within 18 months of formation and was acquired by Boston Scientific Corporation in 1995. Prior to Vesica, Kevin led medical device investment activity at DSV Partners in Newport Beach, California. Kevin has served on the Board of Directors of the New England Venture Capital Association and MassMEDIC, the Massachusetts Medical Device Industry Council. He has served on the Board of Directors of Cothrerix (acquired by Actrilign), Vesica Medical, Inc. (acquired by Boston Scientific), Masimo Corp. (Nasdaq: MASI), Pilot Cardiovascular (acquired by CR Bard), Circe Biomedical (acquired by Valient Pharmaceuticals), Gamera Bioscience (acquired by Tecan AG), and Endonetics (acquired by Medtronic).

He currently serves on the board of Intrinsic Orthopedics, Facet Solutions, Interlace Medical, and Solace Therapeutics. Kevin received a B.S. in Electrical Engineering from the University of Notre Dame, an M.S. in Electrical Engineering from the University of Dayton, and an M.B.A. from the Harvard Business School.